Company Overview

Development Stage

About the Company

[Summary] An innovative enterprise dedicated to the integration of research and

Chongqing Xinsaiya Biotechnology Co., Ltd. is located in the Shuitu High-tech Industrial Park, Liangjiang New Area, Chongqing. It is a production-oriented enterprise established in 2016 in Chongqing Liangjiang New Area by Kangnaide (Beijing) Biotechnology Co., Ltd., a high-tech enterprise in Zhongguancun, Beijing, focusing on the research and development, production, sales, and service of POCT reagents in the field of in vitro diagnostics. Our company has R&D centers in the United States, Beijing, and Chongqing, and has a technical team of PhDs and Masters with rich R&D experience. After years of research, we have made breakthrough progress in quantum dot POCT technology. Our quantum dot immunofluorescence analysis technology is at the leading level internationally.
At present, nearly 20 of our products have been successfully launched and sold. Our product lines are based on inflammation series, cardiac series, glycation items, and bone metabolism series, featuring maternal and child health series, especially vitamin D items, and with advantages in the world's first quantum dot methodology rapid detection of gastric function items (PG1/PG2+G17+gastric Helicobacter pylori typing HP), VEGF, and AMH items. The company has more than 80 projects under research and application, and the novel coronavirus (SARS-CoV-2) IgM/IgG antibody detection kit project has also been successfully developed. Xinsaiya, moving forward, will continue to enrich our product lines at a rate of more than 10 new projects launched each year. At present, our business not only covers the whole country but has also stepped out of the country, reaching strategic cooperation with multiple countries and regions.
Relying on advanced technological resources and an excellent team, Xinsaiya provides faster and more accurate detection methods to assist clinical formulation of effective treatment plans, improve patient treatment outcomes, improve people's quality of life, and reduce social medical costs. With the original intention that "talent is the core competitiveness of the enterprise", the company sincerely welcomes outstanding you to join all Xinsaiya people in dedicating passion, growing together, and moving toward a better tomorrow for Xinsaiya!
Award Information
July 2018 Selected as a "Chongqing Key Project of Technology Innovation and Application Demonstration"
October 2018 Awarded the title of "Chongqing New-type Enterprise R&D Institution"
December 2018 Rated as an outstanding enterprise in the "7th China Innovation and Entrepreneurship Competition Biomedical National Finals"
November 2019 Awarded "Chongqing 2019 High-tech Enterprise"

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Xinsaiya Biotechnology How Fast Is Hiring Growing? (48 open positions)

Manage
Note: How fast is hiring at Chongqing Xinsaiya Biotechnology Co., Ltd. growing? Xinsaiya Biotechnology2025: 210 openings (up 40%), 2024: 150 openings (up 65%), 2023: 91 openings (up 18%), 2022: 77 openings (down 53%), 2021: 164 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Xinsaiya Biotechnology Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Down 67%
  • 2024: Down 25%
  • 2023: Down 20%
  • 2022: Up 11%
Xinsaiya Biotechnology Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Chongqing Xinsaiya Biotechnology Co., Ltd. growing? Xinsaiya BiotechnologyMaster's recruitment over the years: 2025: 2 openings (down 67%), 2024: 6 openings (down 25%), 2023: 8 openings (down 20%), 2022: 10 openings (up 11%), 2021: 9 openings.

Xinsaiya Biotechnology Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
Xinsaiya Biotechnology Doctoral Hiring by Year: 2024 — same as 2023
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Chongqing Xinsaiya Biotechnology Co., Ltd. growing? Xinsaiya BiotechnologyDoctorate recruitment over the years: 2024: 2 openings (down 25%), 2023: 2 openings (down 20%), 2022: 2 openings (up 11%).

Xinsaiya Biotechnology R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Chongqing Xinsaiya Biotechnology Co., Ltd.? Based on an analysis of Xinsaiya Biotechnology's job postings over the past year, "其他(研发和技术类)" demand: 6.3%, "计算机/网络/技术类": 5.8%, "机械/仪器仪表类": 5.3%, "生物/制药/化工/环保类": 4.9%, "医疗卫生/美容保健类": 3.9%. For reference only.

Xinsaiya Biotechnology — What Are the Salaries Like? (206 records)

Manage
Xinsaiya Biotechnology Salary Overview
salary range: 2K - 30K, 43.2% of roles pay ¥10-20K
Note: salary statistics are based on 206 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Chongqing Xinsaiya Biotechnology Co., Ltd.?Xinsaiya Biotechnology43.2% of positions earn 10-20K, Fresh graduate salary: ¥3.9K。销售类 average salary ¥15.8K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Xinsaiya Biotechnology

(More)
Are salaries high at Chongqing Xinsaiya Biotechnology Co., Ltd.? We provide: 销售,实习生,技术工程师,国际贸易,仓储,售后,国际注册,商务专员,质量,运营,采购,注册工程师,研发工程师,西班牙语,qc,体系工程师,技术支持,生产主管,工艺技术,库房. Click to view detailed salary analysis by job.

Xinsaiya Biotechnology honors, qualifications & industry associations

Xinsaiya Biotechnology Related Industry Tags

Job Category

  • 销售类
    33% of total 33%
  • 经营管理类
    18.2% of total 18.2%
  • 贸易/物流/采购/运输类
    14.4% of total 14.4%
  • 技工类
    12.4% of total 12.4%

Education

  • 大专
    52.2% of total 52.2%
  • 本科
    40.2% of total 40.2%
  • 不限
    4.3% of total 4.3%
  • 高中
    2.4% of total 2.4%

Experience

  • 3-5年
    31.1% of total 31.1%
  • 1-3年
    27.3% of total 27.3%
  • 5-10年
    25.4% of total 25.4%
  • 不限
    11.5% of total 11.5%
View Detailed Analysis

What does Chongqing Xinsaiya Biotechnology Co., Ltd. require? Who is Xinsaiya Biotechnology hiring? Xinsaiya Biotechnology recruitment: 销售类占比最多占33%,其次是经营管理类占18.2%. What education can get in at Xinsaiya Biotechnology? 大专占比最多占52.2%,其次是本科占40.2%. High education required at Xinsaiya Biotechnology? 硕士占1%. Work experience required at Xinsaiya Biotechnology? 3-5年占比最多占31.1%,其次是1-3年占27.3%. Where are the job locations at Xinsaiya Biotechnology? 重庆占比最多占72.7%,其次是广州占6.7%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 1,189.9634万(元)
Legal Representative: 张念林
Date Established:
Credit Code: 91500000MA5U60006X
Registered Address: 重庆市北碚区京东方大道388号

Partners & Suppliers

合作进行新型冠状病毒抗体检测试剂盒的临床试验 Source
供应商 医疗机构

People who follow Xinsaiya Biotechnology also follow

Xinsaiya Biotechnology Competitors (Similar Companies)

“A professional ophthalmic medical equipment manufacturer in China”
建筑工程 施工总承包 公路工程 市政公用工程
生产 化工原料 化学品 新材料
深沟球轴承 圆锥滚子轴承 滚子 汽车零部件/配件
过滤器 阀门 减压器 试验台
灯饰 灯光设计 照明 灯具
切割机 机床 数控冲床 折弯机
保险杠 汽车工业 俄罗斯跨境电商 美国跨境电商
“A provider of semiconductor display technology, products, and services”
装修/装饰/装潢 门窗 幕墙 栏杆
精密机械 轴承 变速箱 轮毂
“Custom chemical synthesis, pharmaceutical intermediates, and new drug ”
“Key pharmaceutical enterprise in Chongqing”
“To provide patients with trustworthy and affordable innovative biologi”
消防设施工程 卷帘 防火门 工程施工

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates